Biogen stock heads into the open after a 2.7 percent gain
Published on 09/23/2026 at 07:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Biogen stock closed at USD 224.87 on the Nasdaq on September 22, 2026, up 2.7 percent from the prior close. The shares outperformed the Nasdaq Composite, which gained 0.45 percent to 27,244.28 in the same session.
September 22, 2026 in numbers
Biogen Inc. (ISIN US09062X1037, Nasdaq: BIIB) traded between USD 219.07 and USD 226.43 before ending at USD 224.87. The session high marked a new 52-week high, while volume reached 262,187 shares, according to MarketBeat.
The move followed stronger-than-expected quarterly figures reported on July 29, 2026, when adjusted earnings per share were USD 3.60 against a consensus estimate of USD 2.94, while revenue reached USD 2.74 billion against USD 2.46 billion expected. Biogen also advanced 3.87 percent in the Nasdaq 100 session, compared with a 0.45 percent rise for the Nasdaq Composite, according to Sharecast.
September 23, 2026 outlook
US exchanges are scheduled to open for the next session on September 23, 2026. Market conditions include a Nasdaq Composite record close at 27,244.28, while Brent crude ended at USD 98.46 per barrel and West Texas Intermediate ended at USD 90.52, according to Sharecast. These market figures are relevant to the biotechnology stock through broad equity-market risk sentiment.
